2013-02-20 07:02:47 -

Oslo, Norway, 20 February 2013 - Algeta ASA (OSE: ALGETA), a company focused on
the development of novel targeted cancer therapeutics, announces that members of
its senior management team will participate in the following upcoming investor
conferences:

 Citi Global Healthcare Conference 2013

     Date: 25-27 February 2013

     Participants:

         Jeff Albers (President, Algeta US)

         Mike Booth (IR)

     Panel date & time: Tuesday 25 February, 2013, 10:20am EST

     Venue: New York, NY, USA


 Credit Suisse Global Healthcare One-on-One Conference

     Date: 5-6 March 2013

     Participants:

         Andrew Kay (President & CEO)

           Oystein Soug (CFO)

         Mike Booth (IR)

     Venue: London, UK


 Carnegie Nordic Healthcare Seminar

     Date: 12 March 2013

     Participants:

         Thomas Ramdahl (EVP & CTO)

         Renate Birkeli (IR)

     Presentation date & time: Tuesday 12 March, 2013, 10:05am CET

     Venue: Stockholm, Sweden



Presentations, where applicable, will be available to download at www.algeta.com
following these events.

                                      ###

For further information, please contact:

 Mike Booth / Renate Birkeli            +47 23 00 67 32

 Communications & Corporate Affairs     ir@algeta.com



 Media enquiries:

 Mark Swallow                           +44 207 638 9571

 Citigate Dewe Rogerson                 mark.swallow@citigatedr.co.uk



 Knut Ekern                             +47 22 04 82 00

 Gambit Hill & Knowlton                 knut.ekern@hkstrategies.com



 Kari Watson                            +1 781 235 3060

 MacDougall Biomedical Communications   kwatson@macbiocom.com



 US investor enquiries:

 Tricia Swanson                         +1 646 378 2953

 The Trout Group                        tswanson@troutgroup.com



About Algeta

Algeta is a company focused on developing novel targeted therapies for patients
with cancer based on its alpha-pharmaceutical platform. The Company is
headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in
Cambridge, MA performing commercial marketing operations in the US. Algeta is
listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information please
visit www.algeta.com.


This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.

Press release: 
 hugin.info/134655/R/1679229/548305.pdf



This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
    
Source: Algeta ASA via Thomson Reuters ONE
[HUG#1679229]